Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization

Area of Science:

• Molecular Biology
• Cancer Research
• Radiotherapy

Background:

• Cellular radioresponse is modulated by molecular mechanisms.
• Translational control of gene expression is a key factor in cellular radioresponse.
• The translational machinery components can determine radiosensitivity.

Purpose of the Study:

• To investigate targeting the translational machinery for radiosensitization.
• To explore the potential of inhibiting translation initiation for tumor-specific radiosensitization.
• To evaluate the role of ribosome biogenesis in radiosensitization.

Main Methods:

• Inhibition of translation initiation factors (eIF4E, eIF4G, eIF4A).
• Targeting cap-binding regulatory kinases (mTOR, Mnk1/2).
• Inhibition of ribosome biogenesis.

Main Results:

• Inhibition of translation initiation machinery components radiosensitizes tumor cells.
• Targeting these pathways leads to reduced expression of DNA repair proteins.
• Overexpression of translational machinery in tumors suggests tumor-specific radiosensitization potential.

Conclusions:

• The translational machinery is a viable target for enhancing radiotherapy efficacy.
• Inhibiting translation initiation and ribosome biogenesis can overcome radioresistance.
• Clinically relevant inhibitors offer potential for patient treatment strategies.